The 2022 Power List Nominations Are Open!
The Ophthalmologist’s annual Power List is back for 2022 and we need your help to make it our best ever list, so nominate your peers now
The Ophthalmologist’s annual Power List is back for 2022 and we need your help to make it our best ever list, so nominate your peers now
Low-dose atropine is shown to be an effective solution for children with myopia
Why ophthalmologists are increasingly using amniotic membrane therapy to treat ocular surface disease
The Ophthalmologist brings you the latest news
For 10 years, The Ophthalmologist has been honoring the most influential people in the field with its annual Power List. This year, we expanded this…
The Ophthalmologist brings you the latest news
We speak with Elad Serfaty, Chief Executive Officer of OrCam Technologies, about assistive technology for patients with low vision
The Ophthalmologist brings you the latest news
Christopher T. Leffler, Stephen G. Schwartz, and Andrzej Grzybowski discuss shifts in glaucoma treatment since the development of the ophthalmoscope
Kirk L. Smick argues that preservative-free eye drops should be the standard of care for glaucoma patients